Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth with Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Trial-Reference-Cited by-同舟云学术

Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth with Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Trial

Published:2024-05-31 Issue: Volume: Page:
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Gruber Noah¹²^ORCID,Wittenberg Avigail²³^ORCID,Brener Avivit²⁴^ORCID,Abiri Shirli²⁵,Mazor-Aronovitch Kineret¹²⁶^ORCID,Yackobovitch-Gavan Michal⁷^ORCID,Averbuch Shay²^ORCID,Ben Ari Tal²⁴,Levek Noah¹⁶^ORCID,Levran Neriya¹⁶^ORCID,Landau Zohar⁶^ORCID,Rachmiel Marianna²³^ORCID,Pinhas-Hamiel Orit¹²⁶^ORCID,Lebenthal Yael²⁴^ORCID

Affiliation:

1. Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children’s Hospital, Chaim Sheba Medical Center, Ramat-Gan, Israel.

2. School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.

3. Pediatric Endocrinology and Diabetes Institute, Shamir (Assaf Harofeh) Medical Center, Beer Yakov, Israel.

4. The Institute of Pediatric Endocrinology, Diabetes, and Metabolism, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

5. Pediatric Endocrine and Diabetes Unit, E. Wolfson Medical Center, Holon, Israel.

6. National Juvenile Diabetes Center, Maccabi Health Care Services, Raanana, Israel.

7. Department of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2024.0148

Reference34 articles.

1. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

2. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

3. ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes

4. Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes

5. Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes